You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ETON Sale Disclosure
Maier Paul V · SEC Form 4 · Filed Aug 31, 2026
Sale
Calculated transaction value
$2.13M
Maier Paul V Director
ETON
Eton Pharmaceutcials
ETON
Transaction date
Aug 28, 2026
Public filing date
Aug 31, 2026
Filing lag
Filed 3 days later
ETON daily price context
Close on/before transaction
$59.78
Aug 28, 2026
First close after public filing
$60.43
Sep 1, 2026
30-day return after filing
-14.79%
Through Sep 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 36,387 shares @ $58.64
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4/A
- Filing identifier
- 0001437749-26-029308
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$3.23M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. ETON | Exercise | Aug 28, 2026 | $0 |
| Eton Pharmaceuticals, Inc. ETON | Exercise | Aug 28, 2026 | $189K |
| Eton Pharmaceuticals, Inc. ETON Current | Sale | Aug 28, 2026 | $2.13M |
| Eton Pharmaceuticals, Inc. ETON | Sale | Aug 28, 2026 | $811.93K |
| Eton Pharmaceuticals, Inc. ETON | Sale | Aug 28, 2026 | $7.91K |
| Eton Pharmaceuticals, Inc. ETON | Exercise | Aug 28, 2026 | $91.38K |
| Eton Pharmaceuticals, Inc. ETON | Exercise | Aug 28, 2026 | $0 |